ICCM — IceCure Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1584371 ·
Israel
Last close
$0.83
Market Cap
$2.84M
52W High
$22.50
52W Low
$0.65
ADV30
141,949
Next earnings
2026-11-18
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 907,000 | 253,000 | -4,424,000 | -4,501,000 | 17,707,000 | 12,034,000 | 5,811,000 |
| Mar 2026 | 911,000 | 295,000 | -4,247,000 | -4,274,000 | 13,303,000 | 8,115,000 | 4,809,000 |
| Dec 2025 | 1,279,000 | 600,000 | -4,216,000 | -4,246,000 | 13,888,000 | 8,897,000 | 4,837,000 |
| Sep 2025 | 850,000 | 277,000 | -3,836,000 | -3,859,000 | 15,078,000 | 4,971,000 | 5,772,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,872,000
Investing CF
$-69,000
Financing CF
$22,506,000
CapEx
$-69,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.60
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-129,211,000
Inventory
$2,545,000
Receivables
$2,067,000
ST Investments
$5,034,000
EBIT TTM
$-16,723,000
Pretax Income TTM
$-16,880,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,947,000
EBITDA
$-16,439,000
Free Cash Flow
$-9,538,000
Enterprise Value
$-4,370,960
Total Cash
$12,034,000
Total Debt
$90,000
Shares Out
3,426,715
Trailing EPS
$-6.78
Book Value
$3.47
ROE
-228.3%
ROA
-73.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,379,000 | -15,094,000 | -15,057,000 | 13,888,000 | 4,837,000 | 9,051,000 | -14,574,000 |
| Dec 2024 | 3,291,000 | -15,696,000 | -15,318,000 | 12,576,000 | 5,675,000 | 6,901,000 | -12,563,000 |
| Dec 2023 | 3,229,000 | -15,576,000 | -14,652,000 | 16,410,000 | 4,247,000 | 12,163,000 | -12,550,000 |
| Dec 2022 | 3,085,000 | -16,739,000 | -16,978,000 | 30,188,000 | 4,766,000 | 25,422,000 | -14,292,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.31
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BDMD | Baird Medical Investment Holdings Ltd | $2.94M | $0.09 | — |
| DROR | Dror Ortho-Design, Inc. | $2.44M | $0.00 | — |
| XAIR | Beyond Air, Inc. | $3.35M | $2.01 | — |
| BJDX | Bluejay Diagnostics, Inc. | $2.41M | $2.15 | — |
| OSRH | OSR Health, Inc. | $3.51M | $0.10 | — |
News headlines (Yahoo Finance, 1h cache)
IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates
2026-11-18 13:35 · Yahoo
IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2026: 83% Year-Over-Year Growth in U.S. Sales and Major Growth in U.S. Commercial Reach to 21 States
2026-11-18 13:25 · Yahoo
IceCure Medical to Report Third Quarter 2026 Financial and Operating Results on November 18, 2026
2026-11-11 13:30 · Yahoo
IceCure Medical Secures New Chinese Patent for Cryogenic Technology Connector
2026-11-09 15:41 · Yahoo
IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP Portfolio
2026-11-09 13:25 · Yahoo
IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
2026-10-27 12:33 · Yahoo
IceCure enrols initial patients for ProSense cryoablation trial in US
2026-10-21 10:46 · Yahoo
IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
2026-10-20 11:55 · Yahoo
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
2026-10-13 12:05 · Yahoo
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
2026-10-06 12:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.